MX2012013835A - Cepas probioticas para aumentar la resistencia transepitelial. - Google Patents
Cepas probioticas para aumentar la resistencia transepitelial.Info
- Publication number
- MX2012013835A MX2012013835A MX2012013835A MX2012013835A MX2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A
- Authority
- MX
- Mexico
- Prior art keywords
- transepithelial resistance
- probiotic strains
- improving
- improving transepithelial
- resistance
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La invención se refiere al uso de bacterias de ácido láctico para aumentar la resistencia transepitelial y más particularmente para tratar y/o prevenir los problemas intestinales tales como constipación y/o enfermedad del intestino irritable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2010/001536 WO2011148220A1 (en) | 2010-05-28 | 2010-05-28 | Probiotic strains for use in improving transepithelial resistance |
PCT/IB2011/052368 WO2011148358A1 (en) | 2010-05-28 | 2011-05-30 | Probiotic strains for use in improving transepithelial resistance |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012013835A true MX2012013835A (es) | 2013-04-08 |
MX346332B MX346332B (es) | 2017-03-15 |
Family
ID=43334416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012013835A MX346332B (es) | 2010-05-28 | 2011-05-30 | Cepas probioticas para aumentar la resistencia transepitelial. |
Country Status (14)
Country | Link |
---|---|
US (1) | US9402872B2 (es) |
EP (1) | EP2575834B1 (es) |
JP (1) | JP5816273B2 (es) |
KR (1) | KR101790683B1 (es) |
CN (1) | CN103079581B (es) |
BR (1) | BR112012030363A2 (es) |
CA (1) | CA2800770C (es) |
EA (1) | EA024443B1 (es) |
ES (1) | ES2514326T3 (es) |
MX (1) | MX346332B (es) |
PL (1) | PL2575834T3 (es) |
PT (1) | PT2575834E (es) |
WO (2) | WO2011148220A1 (es) |
ZA (1) | ZA201208978B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011148219A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
RU2606770C2 (ru) * | 2011-12-21 | 2017-01-10 | Компани Жервэ Данон | Штамм lactobacillus mucosae для получения ферментированных пищевых продуктов |
WO2014096901A1 (en) | 2012-12-18 | 2014-06-26 | Compagnie Gervais Danone | Strain of bifidobacterium animalis ssp. animalis |
CN117837746A (zh) * | 2015-07-10 | 2024-04-09 | 帝斯曼知识产权资产管理有限公司 | 用于预防和治疗炎性疾病的食物和/或饲料组合物 |
AU2022418271A1 (en) | 2021-12-22 | 2024-06-20 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1119154C (zh) * | 1998-01-20 | 2003-08-27 | 上海信谊药业有限公司 | 双歧三联活菌制剂及制备方法 |
US20030092163A1 (en) | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
DE602006006997D1 (de) * | 2005-05-16 | 2009-07-09 | Univ Liege | Probiotische bifidobacterium arten |
AU2006296837B2 (en) | 2005-09-28 | 2012-12-13 | Nordic Rebalance A/S | Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors |
PL1981516T3 (pl) * | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
EP2072053B1 (en) | 2007-12-21 | 2012-11-07 | Compagnie Gervais Danone | Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
WO2009158384A1 (en) * | 2008-06-27 | 2009-12-30 | The Procter & Gamble Company | Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders |
-
2010
- 2010-05-28 WO PCT/IB2010/001536 patent/WO2011148220A1/en active Application Filing
-
2011
- 2011-05-30 WO PCT/IB2011/052368 patent/WO2011148358A1/en active Application Filing
- 2011-05-30 PL PL11727794T patent/PL2575834T3/pl unknown
- 2011-05-30 MX MX2012013835A patent/MX346332B/es active IP Right Grant
- 2011-05-30 EP EP11727794.7A patent/EP2575834B1/en active Active
- 2011-05-30 JP JP2013511784A patent/JP5816273B2/ja active Active
- 2011-05-30 ES ES11727794.7T patent/ES2514326T3/es active Active
- 2011-05-30 KR KR1020127034390A patent/KR101790683B1/ko active IP Right Grant
- 2011-05-30 BR BR112012030363A patent/BR112012030363A2/pt not_active Application Discontinuation
- 2011-05-30 PT PT117277947T patent/PT2575834E/pt unknown
- 2011-05-30 EA EA201291440A patent/EA024443B1/ru not_active IP Right Cessation
- 2011-05-30 CN CN201180026423.5A patent/CN103079581B/zh active Active
- 2011-05-30 CA CA2800770A patent/CA2800770C/en active Active
- 2011-05-30 US US13/700,482 patent/US9402872B2/en active Active
-
2012
- 2012-11-28 ZA ZA2012/08978A patent/ZA201208978B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2800770A1 (en) | 2011-12-01 |
BR112012030363A2 (pt) | 2016-08-09 |
EP2575834A1 (en) | 2013-04-10 |
KR101790683B1 (ko) | 2017-10-26 |
CN103079581A (zh) | 2013-05-01 |
WO2011148358A1 (en) | 2011-12-01 |
ZA201208978B (en) | 2014-04-30 |
US20130216510A1 (en) | 2013-08-22 |
EP2575834B1 (en) | 2014-06-25 |
EA201291440A1 (ru) | 2013-04-30 |
PL2575834T3 (pl) | 2015-03-31 |
WO2011148220A1 (en) | 2011-12-01 |
ES2514326T3 (es) | 2014-10-28 |
JP5816273B2 (ja) | 2015-11-18 |
PT2575834E (pt) | 2014-10-01 |
EA024443B1 (ru) | 2016-09-30 |
JP2013527194A (ja) | 2013-06-27 |
US9402872B2 (en) | 2016-08-02 |
MX346332B (es) | 2017-03-15 |
CN103079581B (zh) | 2015-08-05 |
KR20130141350A (ko) | 2013-12-26 |
CA2800770C (en) | 2019-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012013834A (es) | Cepas probioticas para mejorar el sistema nervioso enterico. | |
IN2012DN01638A (es) | ||
IN2012DN02463A (es) | ||
GB2480042A (en) | Prebiotic formulations and methods of use | |
MX2019009132A (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
IN2012DN02737A (es) | ||
UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
WO2012112777A3 (en) | Biosynthesis of human milk oligosaccharides in engineered bacteria | |
MX2011005527A (es) | Uso de la bacteria de acido lactico para tratar o prevenir el eczema. | |
BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
GB2482536B (en) | Expression of antibody or a fragment thereof in lactobacillus | |
MX2015006491A (es) | Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas. | |
WO2011110918A8 (en) | Composition comprising probiotic bacteria for use in the treatment of immune disorders | |
MX2011011670A (es) | Inmunoglobulinas de dominio variable dual y usos de las mismas. | |
GB2511993A (en) | Prebiotic formulations and methods of use | |
PL2753687T3 (pl) | Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium | |
IN2012DN00624A (es) | ||
MX2011008398A (es) | Lactobacillus helveticus cncm i-4095 y el control del peso. | |
MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
MX2011008400A (es) | Lactobacillus rhamnosus cncm i-4096 y el control del peso. | |
MX346332B (es) | Cepas probioticas para aumentar la resistencia transepitelial. | |
WO2012019054A3 (en) | Expression of antibody or a fragment thereof in lactobacillus | |
HK1173182A1 (en) | Proliferation-enhancing agent and or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus | |
MX2012007970A (es) | Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico. | |
IN2014DN08385A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |